NuCyRNA Therapeutics
NuCyRNA Therapeutics

Pagliuca Harvard Life Lab

NuCyRNA Therapeutics

Redefining RNA-targeting therapeutics, starting in neurodegenerative diseases.
Nucyrna team lead

2025 President’s Innovation Challenge Finalist

Founders

Feng (Damon) Wang

Harvard University

About NuCyRNA Therapeutics

School

Harvard Medical School

Lab

Pagliuca Harvard Life Lab

Programs

Pagliuca Harvard Life Lab

Connect

Website

Awards & Affiliations

  • 2025

    President's Innovation Challenge Finalist

    Alumni + Affiliates Health Care + Life Sciences Track

More Pagliuca Harvard Life Lab Ventures